Explore more publications!

Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

Press releases published on November 25, 2025

RedCloud’s CEO Floyd To Join NVIDIA, Google, Amazon, At Exclusive AI Summits in Tokyo and Doha
Silexion Therapeutics Successfully Completes Toxicology Studies for SIL204, Next-Generation RNA Silencing Therapy, Ahead of Phase 2/3 Clinical Trial in Pancreatic Cancer
Synaptics to Participate at Upcoming Investor Conferences on Tuesday, December 2, 2025 and Wednesday, December 10, 2025
Telnyx and Yeastar partner to empower businesses with complete control over their Unified Communications
Compliant Launches Agentic AI Suite for Programmatic Media
Akari Therapeutics Announces Release of the Next CEO Corner Segment
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
Ragic Shortlisted in The 2025/26 Cloud Awards
Sagtec Delivers 226% Surge in Net Profit as Revenue Nearly Doubles in 2025 Interim Results
SEALSQ QS7001 Quantum-Resistant Secure Element Delivers  Immediate CNSA 2.0 Compliance with Hardware-Embedded Post-Quantum Cryptography
Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital
Diagnos annonce l'augmentation du montant du placement privé par intermédiaire d'un courtier précédemment annoncé à 3,65 millions de dollars, mené par Centurion One Capital
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
Helport AI and UMass Lowell Launch AI Entrepreneurship Competition
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
American Rebel Holdings, Inc. (NASDAQ: AREB) Expands Kroger Footprint as Downtown Nashville Kroger Flagship Store #502 Adds American Rebel Light Beer
BlackLine Issues Statement Regarding Shareholder Engagement
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions